Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 12
- +1 vs. Q1 2024
- Portfolio value
- $19.7M
- +$2.18M (+12.4%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ACETAdicet Bio, Inc. | COM | 17,488 | $21.2K | 0.1% | 00.0% | Unchanged | History |
| CNTXContext Therapeutics Inc. | COM | 18,403 | $36.9K | 0.2% | +18,403 | New | History |
| CMPXCompass Therapeutics, Inc. | COM | 43,465 | $43.5K | 0.2% | 00.0% | Unchanged | History |
| MTEMMolecular Templates, Inc. | COM NEW | 136,866 | $157.4K | 0.8% | 00.0% | Unchanged | History |
| KYTXKyverna Therapeutics, Inc. | COM | 22,981 | $172.4K | 0.9% | +7,135+45.0% | Added | History |
| ABVXAbivax S.A. | SPONSORED ADS | 13,900 | $183.8K | 0.9% | −1,908−12.1% | Reduced | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 30,383 | $219.1K | 1.1% | +1,318+4.5% | Added | History |
| LXEOLexeo Therapeutics, Inc. | COM | 17,851 | $286.3K | 1.5% | +7,532+73.0% | Added | History |
| BRK.BBerkshire Hathaway Inc | Stock | 1,025 | $417.1K | 2.1% | +6+0.6% | Added | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 1,869 | $1.02M | 5.2% | +13+0.7% | Added | History |
| RZLTRezolute, Inc. | COM NEW | 1,318,967 | $5.67M | 28.7% | 00.0% | Unchanged | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 5,113,348 | $11.5M | 58.3% | 00.0% | Unchanged | History |